Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-11-08

Clinical Trial Update: Facilitating Migraine Medication Adherence and Optimizing Medication Use

View source ↗

Summary

This clinical trial update notes that the study aimed at improving adherence to migraine medications and optimizing their use has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Headache | Status: WITHDRAWN